Welcome to our dedicated page for Clarivate Plc SEC filings (Ticker: CLVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Clarivate Plc (NYSE: CLVT), a company incorporated in Jersey, Channel Islands and described as a leading global provider of transformative intelligence. Through these filings, investors and analysts can review how Clarivate reports on its financial performance, capital structure and key corporate events related to its activities in Academia & Government, Intellectual Property and Life Sciences & Healthcare.
Clarivate uses Form 8-K to disclose material events, including quarterly earnings announcements and supplemental information on revenue, earnings and guidance. These filings typically reference press releases and investor presentations that are made available through the company’s investor relations channels. Other 8-K filings cover topics such as amendments to the company’s credit agreement, which detail changes to revolving credit commitments and related terms, and updates on leadership transitions or board changes.
By reviewing Clarivate’s SEC filings, users can track how the company finances its operations, including the use of revolving credit facilities, and how it communicates significant developments to the market. Filings also confirm corporate details such as Clarivate’s jurisdiction of incorporation, references to offices in London, United Kingdom, and its registration under Commission File Number 001-38911.
On Stock Titan, these documents are updated as they are posted to the SEC’s EDGAR system. AI-powered tools can help summarize lengthy filings, highlight key sections and surface items such as earnings disclosures, material agreements and governance changes, allowing users to understand the implications of Clarivate’s regulatory reporting more quickly and efficiently.
Clarivate (CLVT) reported Q3 2025 results with revenue of $623.1 million, essentially flat year over year. Income from operations improved to $44.0 million from $21.7 million as cost controls offset higher depreciation and amortization. Net loss narrowed to $28.3 million from $65.6 million, and interest expense declined to $68.5 million from $72.2 million.
Year to date, revenue was $1,838.2 million versus $1,893.7 million, reflecting divestitures and product wind-downs. Segment Adjusted EBITDA totaled $252.4 million in the quarter. Operating cash flow reached $468.6 million for the nine months, supporting capital expenditures of $192.5 million and share repurchases of $149.5 million for approximately 34.8 million shares. Long-term debt was $4,419.0 million, down from $4,518.7 million, aided by redeeming $600.0 million of 2026 senior secured notes and adding a $500.0 million Tranche 2 term loan. Ordinary shares outstanding were 661,435,069 as of September 30, 2025.
Clarivate Plc furnished an update on operations by releasing its earnings press release for the third quarter ended September 30, 2025. The company made the press release available as Exhibit 99.1 and posted it on its investor relations website.
The company also furnished supplemental materials covering revenue, earnings, and guidance as Exhibit 99.2, likewise posted on its investor relations site. The materials in Items 2.02 and 7.01 are being furnished and are not deemed filed under the Exchange Act.
Andrew M. Snyder, a director of Clarivate Plc (CLVT), reported stock award and withholding transactions dated 09/30/2025. He received 13,381 ordinary shares as a quarterly election in lieu of a $51,250 cash retainer, calculated at the closing price of $3.83 per share. 419 shares were withheld to satisfy taxes, leaving Mr. Snyder with 177,870 shares directly beneficially owned after the award. The filing also discloses large indirect holdings through related entities, including 8,821,984, 787,510, 10,489,466, and 4,033,271 ordinary shares held by Cambridge Information Group affiliates, and 238,500 shares held by the Snyder 2011 Family Trust.
Mourad Maroun S., a director and President, IP of Clarivate plc (CLVT), reported insider acquisitions on 09/15/2025. The filing shows 539,568 ordinary shares acquired directly at a reported price of $0, and 105,000 ordinary shares held indirectly by spouse. No derivative securities were reported. The form was signed by an attorney-in-fact on 09/16/2025.
Mourad Maroun S., a director and President, IP at Clarivate plc (CLVT), reported ownership of 105,000 ordinary shares held indirectly through his spouse. The Form 3 reflects an event dated 09/08/2025 and the filing bears a signature by an attorney-in-fact dated 09/16/2025. No derivative securities or additional holdings are disclosed.
Clarivate Plc (CLVT) submitted a Form 144 notice for a proposed sale of 100,000 common shares. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value reported as $426,370.00 and approximately 672,219,064 shares outstanding. The filer indicates these were acquired as restricted stock from the issuer on 08/13/2025 and payment was recorded the same day. An earlier sale of 100,000 common shares by the same person on 07/01/2025 generated gross proceeds of $453,000.00. The notice includes the required representation that the seller is unaware of undisclosed material adverse information.
Clarivate Plc director and officer Henry Levy reported a withholding of 70,746 ordinary shares on 08/13/2025 to satisfy taxes arising from the vesting of restricted share units; the withholding price per share was $4.26. After this withholding disposition, Mr. Levy beneficially owns 679,920 ordinary shares directly. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/15/2025. The filing identifies the transaction code F, and explicitly states the shares were withheld for taxes upon RSU vesting.
Clarivate PLC (CLVT) insider Shem Tov Matitiahu S., listed as Chief Executive Officer and Director, reported a transaction dated 08/13/2025. The filing shows 90,662 ordinary shares were disposed at a reported price of $4.26. After the transaction the reporting person beneficially owned 1,331,811 shares directly and 320,603 shares indirectly through IBI Trust Management. The form states the 90,662 shares were withheld for taxes upon vesting of restricted share units, indicating the disposition related to tax withholding rather than an open-market sale.
Clarivate Plc insider transaction by William E. Graff: The filing reports a non-derivative disposition of 23,525 ordinary shares on 08/13/2025 at a price of $4.26 per share. The form states these shares were withheld to satisfy taxes upon the vesting of restricted share units. After the reported transaction, Mr. Graff beneficially owns 615,146 ordinary shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/15/2025. No derivative transactions or other changes in indirect ownership are reported. The filing documents an internal tax-withholding sale tied to equity compensation rather than an open-market purchase or a standalone sale for liquidity.
Samson James Gordon, listed as an officer (President, IP) and director of Clarivate PLC (CLVT), reported a non-sale disposition on 08/13/2025 where 22,581 ordinary shares were withheld for taxes upon the vesting of restricted share units at a price of $4.26 per share. After this tax withholding, Mr. Gordon beneficially owned 1,248,522 ordinary shares directly. The Form 4 was executed by an attorney-in-fact on behalf of the reporting person.